tiprankstipranks
Ocumension Therapeutics (HK:1477)
:1477
Hong Kong Market
1477
Ocumension Therapeutics
RESEARCH TOOLSreports

Ocumension Therapeutics (1477) Stock News & Sentiment

1 Followers
Ocumension Enrolls First Patient in China Phase III Trial for FDA-Approved Dry Eye Drug OT-211
Premium
Company Announcements
Ocumension Enrolls First Patient in China Phase III Trial for FDA-Approved Dry Eye Drug OT-211
15d ago
1477
Ocumension Nearly Doubles Revenue in 2025 and Turns EBITDA Positive on Ophthalmic Portfolio Growth
Premium
Company Announcements
Ocumension Nearly Doubles Revenue in 2025 and Turns EBITDA Positive on Ophthalmic Portfolio Growth
19d ago
1477
Ocumension Plans Board Refresh With New Independent Director After Wu’s Retirement
Premium
Company Announcements
Ocumension Plans Board Refresh With New Independent Director After Wu’s Retirement
19d ago
1477
Ocumension Sets March Board Meeting to Approve 2025 Results and Mull Dividend
Premium
Company Announcements
Ocumension Sets March Board Meeting to Approve 2025 Results and Mull Dividend
1M ago
1477
Ocumension Completes Patient Enrollment for Real-World Study of OT-703 in Hainan
Premium
Company Announcements
Ocumension Completes Patient Enrollment for Real-World Study of OT-703 in Hainan
3M ago
1477
Ocumension Increases Treasury Share Holdings to Nearly 21 Million
Premium
Company Announcements
Ocumension Increases Treasury Share Holdings to Nearly 21 Million
4M ago
1477
Ocumension Therapeutics Gains Approval for OT-702 in China
Premium
Company Announcements
Ocumension Therapeutics Gains Approval for OT-702 in China
5M ago
1477
More HK:1477 News >

1477 News on the Web

CICC Sticks to Their Buy Rating for Ocumension Therapeutics (1477)
TipRanks News
Bullish
Ocumension Enrolls First Patient in China Phase III Trial for FDA-Approved Dry Eye Drug OT-211
TipRanks News
Bullish
Ocumension Nearly Doubles Revenue in 2025 and Turns EBITDA Positive on Ophthalmic Portfolio Growth
TipRanks News
Bullish
Ocumension Plans Board Refresh With New Independent Director After Wu’s Retirement
TipRanks News
Neutral
Ocumension Sets March Board Meeting to Approve 2025 Results and Mull Dividend
TipRanks News
Neutral
Ocumension Therapeutics Gains Approval for Phase III Trial of Presbyopia Treatment in China
TipRanks News
Neutral
Ocumension Therapeutics Proposes Amendments to Optimize Operations
TipRanks News
Neutral
Ocumension Therapeutics Reports Significant Revenue Growth in 2024
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:1477’s Media Buzz Sentiment?
Currently, no data Available
What is HK:1477’s weekly average amount of articles?
Currently, no data Available
What is HK:1477’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
ALLOAllogene Therapeutics
STAAStaar Surgical
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week